We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202

News   Jun 03, 2015

 
MorphoSys Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202
 
 
 

RELATED ARTICLES

Cracking a One-Two Punch Against Melanoma

News

Updated, safer versions of diphtheria fusion toxin DAB-IL-2 show promise in reducing tumor growth.

READ MORE

Lung Therapy Targets Derived From Fetal Signaling Pathways

News

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought.

READ MORE

Therapy Combo Promising in Small Cell Lung Cancer Model

News

A combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE